Loading organizations...
Loading organizations...
Development and production of enzymes and antibodies for diagnostics.
Vazyme Biotech has raised $77.5M across 1 funding round.
Vazyme Biotech has raised $77.5M in total across 1 funding round.
Vazyme Biotech has raised $77.5M in total across 1 funding round.
Vazyme Biotech's investors include China Life.
Vazyme Biotech has raised $77.5M across 1 funding round. Most recently, it raised $77.5M Series C in May 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 12, 2020 | $77.5M Series C | China Life |